ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

PPBT Purple Biotech Ltd

0.5499
0.0206 (3.89%)
2024年5月11日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Purple Biotech Ltd PPBT NASDAQ Depository Receipt
  前日比 前日比 % 現在値 時刻
0.0206 3.89% 0.5499 13:00:02
始値 安値 高値 終値 前日終値
0.53 0.501 0.5613 0.5251 0.5293
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2520:00GLOBEPurple Biotech's Randomized Phase 2 CM24 Pancreatic Cancer..
2024/3/2820:00GLOBEPurple Biotech to Present New Data On its Oncology Drug..
2024/3/1420:30GLOBEPurple Biotech Reports Preclinical Proof of Concept for its..
2024/3/0706:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/3/0606:00EDGAR2Form 20-F - Annual and transition report of foreign private..
2024/3/0521:58EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/3/0521:55GLOBEPurple Biotech Reports Fourth Quarter and Full-Year 2023..
2024/2/2721:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/2721:00GLOBEPurple Biotech Presents Data of its Phase 1 Head & Neck..
2024/2/1321:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/1321:00GLOBEPurple Biotech Convenes a Head & Neck Cancer Scientific..
2024/2/0121:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/0121:30GLOBEPurple Biotech Reaches Recommended Phase 2 Dose for NT219
2024/1/2706:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/2022:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/2022:05GLOBEPurple Biotech Appoints Dr. Yael Margolin to its Board of..
2023/12/1421:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/1420:50GLOBEPurple Biotech Completes Patient Enrollment in Phase 2..
2023/11/2121:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/2120:50GLOBEPurple Biotech Reports Third Quarter 2023 Financial Results
2023/11/1514:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/11/1506:13EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/11/1406:11EDGAR2Form F-1/A - Registration statement for certain foreign..
2023/11/0220:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/0220:00GLOBEPurple Biotech Fortifies NT219 Patent Protection
2023/10/3105:30EDGAR2Form F-1 - Registration statement for certain foreign..
2023/10/2005:40EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/10/2005:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/2004:55GLOBEPurple Biotech Announces Closing of $5 Million Registered..
2023/10/1923:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/1923:27EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/10/1721:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/1721:00GLOBEPurple Biotech Announces $5 Million Registered Direct..
2023/10/1720:03EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/10/1320:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/0621:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/0620:50GLOBEPurple Biotech Reports Potential Biomarker Data Support..
2023/10/0321:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/0320:50GLOBEPurple Biotech Reports Positive Interim and Preliminary..
2023/9/2121:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/2121:00GLOBEPurple Biotech to Present New CM24 Pancreatic Cancer..
2023/9/1321:39EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/2222:29GLOBEPurple Biotech Reports Second Quarter 2023 Financial Results
2023/8/2221:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/7/1121:20EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/7/1121:15GLOBEPurple Biotech Reports Positive Results of CM24 Dose..

最近閲覧した銘柄

Delayed Upgrade Clock